Mesoblast (MESO) Change in Working Capital (2022 - 2025)
Mesoblast's (MESO) quarterly Change in Working Capital came in at -$6.5 million in Q4 2025, up 43.53% year-on-year from -$4.6 million in Q4 2024, and up 43.53% quarter-over-quarter from -$11.6 million in Q4 2024.
Mesoblast (MESO) Change in Working Capital (2022 - 2025) Analysis & Trends
Mesoblast has disclosed Change in Working Capital across 4 years of filings, most recently posting -$6.5 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | -6.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.55 Mn |
| Dec 31, 2025 | -6.55 Mn |
| Dec 31, 2024 | -11.59 Mn |
| Dec 31, 2024 | -11.59 Mn |
| Dec 31, 2023 | -10.82 Mn |
| Dec 31, 2023 | -10.82 Mn |
| Mar 31, 2023 | -13.49 Mn |
| Mar 31, 2023 | -13.49 Mn |
| Dec 31, 2022 | -8.59 Mn |
| Dec 31, 2022 | -8.59 Mn |